NeOnc Technologies Prices $15M Registered Direct Offering With Institutional Investors

NeOnc Technologies Holdings entered definitive securities purchase agreements with new and existing healthcare-focused institutional investors for a registered direct offering expected to raise approximately $15 million in gross proceeds. The financing strengthens near-term liquidity but may be viewed negatively by existing shareholders because registered direct equity offerings typically create dilution.